Clinical Trials in Dallas

Showing 8021-8040 of 17,468 trials

Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic Adenocarcinoma

NCT03318497

To assess if percentage change in 18F-FLT PET/CT quantitative parameters (SUV max, or SUV peak or proliferative tumor volume) after 2 cycles of neoadjuvant chemotherapy can predict overall survival at 1 and 2 years and progression free survival at 6 months and 1 year in patients with borderline resectable or locally advanced, pancreatic adenocarcinoma.

Pancreatic Adenocarcinoma

University of Texas Southwestern Medical Center6 participantsStarted Dec 2017

Dallas, Texas, United States

COMPLETEDPhase 4< 1 mile

Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants

NCT04922645

This study is being conducted to demonstrate the effect of Auryxia, when used as the primary phosphate lowering therapy, on the overall cumulative use of erythropoiesis-stimulating agent and intravenous iron as well as on the laboratory parameters indicative of phosphate and anemia management.

HyperphosphatemiaAnemia, Iron DeficiencyRenal Insufficiency

USRC Kidney Research214 participantsStarted Jun 2021

Anchorage, Alaska, United States • Mesa, Arizona, United States • Pine Bluff, Arkansas, United States +10 more locations

Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic Adenocarcinoma

Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants

Find Trials by Condition in Dallas

A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis

Randomized, Double-Blind, Placebo-Controlled Trial, Followed by Single-Arm Treatment of PRO 140

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy

Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)

Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease

Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects

An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)

Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC

A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy